Sort
1,049,261 grants matching “t cell”
DETECTION AND MODELS OF TOXICANT EXPOSURE
$2,363,608Robert H Tukey · University Of California, San Diego · P42 · FY2020 · ES
Pathway Analysis in Tuberculosis
$2,363,433Sabine Ehrt · Weill Medical Coll Of Cornell Univ · P01 · FY2023 · AI
Deconvolution of adaptive metabolic responses of the endoplasmic reticulum
$2,363,388Gokhan S Hotamisligil · Harvard School Of Public Health · RC4 · FY2010 · DK
Molecular Therapies for Cystic Fibrosis Lung Disease
$2,363,383Paul B McCray · University Of Iowa · P01 · FY2020 · HL
Structure and Genesis of tau Aggregates
$2,363,370Jeff A Kuret · Ohio State University · RF1 · FY2017 · AG
Exosomes as mediators of cardiac injury and repair
$2,363,250Raj Kishore · Temple Univ Of The Commonwealth · P01 · FY2017 · HL
The New Zimmerman Program for the Genetics and Biology of von Willebrand Factor and von Willebrand Disease
$2,363,224Jorge A Dipaola · Washington University · P01 · FY2025 · HL
Scanning Probe Microscopy for the Intramural Research Community
$2,363,191Emilios K Dimitriadis · National Institute Of Biomedical Imaging And Bioengineering · ZIC · FY2020 · EB
Three-Dimensional Cell and Tissue Reconstruction by Serial Block Face SEM
$2,363,191Richard Leapman · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2020 · EB
Pathogenesis and Therapeutic Approaches in Primary Ciliary Dyskinesia
$2,363,088David A Stoltz · University Of Iowa · P01 · FY2025 · HL
CENTER FOR RECOMBINANT GAMETE CONTRACEPTIVE VACCINOGENS
$2,363,015University Of Virginia Charlottesville · U54 · FY2001 · HD
Attacking failure of antibiotic treatment by targeting antimicrobial resistance enabler cell-states
$2,362,994Tim Van Opijnen · Broad Institute, Inc. · U19 · FY2022 · AI
Vascular Biology: Exercise Training and Vascular Disease
$2,362,882M Harold Laughlin · University Of Missouri-Columbia · P01 · FY2009 · HL
THIS IS A CONTINUATION OF N00014-13-1-0074 NEXT-GENERATION GENETIC DEVICES: MODEL-GUIDED DISCOVERY AND OPTIMIZATION OF NAVY-RELEVANT CELL-BASED SENSO
$2,362,813Massachusetts Institute Of Technology · · FY2016 · Department of Defense
Harvard-wide Program on Antibiotic Resistance
$2,362,774Michael S. Gilmore · Massachusetts Eye And Ear Infirmary · P01 · FY2022 · AI
Delaware Center for Musculoskeletal Research
$2,362,765Dawn M Elliott · University Of Delaware · P20 · FY2022 · GM
Pre-clinical Translational Research Facility
$2,362,658Mark Gilbert · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA
HEALIH EFFECTS AND GEOCHEMISTRY OF ARSENIC AND LEAD
$2,362,545Columbia University Health Sciences · P42 · FY2004 · ES
HEALIH EFFECTS AND GEOCHEMISTRY OF ARSENIC AND LEAD
$2,362,545Columbia University Health Sciences · P42 · FY2005 · ES
Exosomes as mediators of cardiac injury and repair
$2,362,544Raj Kishore · Temple Univ Of The Commonwealth · P01 · FY2018 · HL
AN IN VIVO APPROACH TO CELL-BASED THERAPY FOR TYPE I DIABETES
$2,362,500Ben Z Stanger · University Of Pennsylvania · DP2 · FY2008 · DK
Amyloid elimination by Hsp104 and substrate-optimized variants
$2,362,500James Shorter · University Of Pennsylvania · DP2 · FY2007 · OD
Gating mechanisms and pharmacology of voltage-activated ion channels
$2,362,491Kenton Swartz · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
Mechanisms of normal and abnormal platelet homeostasis
$2,362,115Joel S. Bennett · University Of Pennsylvania · P50 · FY2006 · HL
New Genes and Pathways Involved in Atherosclerosis
$2,362,079Alan Richard Tall · Columbia University Health Sciences · P01 · FY2009 · HL